Clinical Scorecard: Impact of Dural Attachment on the Progression of Residual Tumors Following Subtotal Resection in WHO Grade 1 Meningiomas

At a Glance

Key Highlights

• Subtotal resection occurs in over 25% of meningioma surgeries, leaving residual tumor at risk of progression.
• Extent of dural attachment of residual tumor may influence progression due to meningioma vascular supply primarily from dura mater.
• MRI tumor signal intensity ratios (T1 and T2 weighted) provide normalized indices correlating with tumor consistency, vascularity, and potential growth behavior.

Guideline-Based Recommendations

Diagnosis

• Use postoperative MRI to identify and delineate residual tumor remnants.
• Assess remnant attachments to dura, vessels, nerves, and brain parenchyma via MRI and surgical records.
• Measure tumor and remnant volumes and maximal diameters using T1-weighted post-gadolinium sequences.

Management

• Consider extent of dural attachment when evaluating risk of residual tumor progression.
• Use MRI signal intensity ratios to inform intraoperative decision-making and postoperative surveillance strategies.
• Follow a postoperative imaging schedule typically at 3, 6, and 12 months, then annually, with tighter controls if progression is suspected.

Monitoring & Follow-up

• Perform serial postoperative MRI scans to monitor remnant tumor volume and growth.
• Evaluate remnant relative area of dural contact quantitatively to assess progression risk.
• Use intensity ratios from MRI to track changes in tumor consistency and vascularity over time.

Risks

• Residual tumor progression risk increases with larger dural attachment area.
• High proliferative indices, peritumoral edema, and large preoperative tumor size are established predictors of progression.
• Uncertainty in differentiating remnant tumor from scar tissue requires careful radiological and surgical correlation.

Patient & Prescribing Data

Adults with WHO grade 1 meningiomas undergoing subtotal resection with residual tumor remnants

Postoperative management should incorporate imaging-based assessment of remnant dural attachment and MRI signal characteristics to stratify progression risk and guide follow-up intensity.

Clinical Best Practices

• Obtain high-quality postoperative MRI including T1-weighted post-gadolinium and T2-weighted sequences for volumetric and intensity analysis.
• Use 3D reconstruction software to quantify remnant tumor volume and dural attachment surface area.
• Integrate surgical findings with imaging to accurately identify remnant attachments and differentiate tumor from scar tissue.
• Apply normalized intensity ratios (tumor to cerebellar peduncle) for inter-patient comparability in tumor characterization.
• Adopt a structured postoperative imaging schedule with flexibility for increased frequency if progression is suspected.

References

• 3D Slicer Software Version 5.2.1